Literature DB >> 12385889

The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system.

Luca M Neri1, Paola Borgatti, Silvano Capitani, Alberto M Martelli.   

Abstract

Lipid second messengers, particularly those derived from the polyphosphoinositide cycle, play a pivotal role in several cell signaling networks. Phosphoinositide 3-kinases (PI3Ks) generate specific inositol lipids that have been implicated in a plethora of cell functions. One of the best-characterized targets of PI3K lipid products is the serine/threonine protein kinase Akt. Recent findings have implicated Akt in cancer progression because it stimulates cell proliferation and suppresses apoptosis. Evidence accumulated over the past 15 years has highlighted the presence of an autonomous nuclear inositol lipid metabolism, and suggests that lipid molecules are important components of signaling pathways operating within the nucleus. PI3Ks, their lipid products, and Akt have also been identified at the nuclear level. In this review, we shall summarize the most updated findings about these molecules in relationship with the nuclear compartment and provide an overview of the possible mechanisms by which they regulate important cell functions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12385889     DOI: 10.1016/s1388-1981(02)00300-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  56 in total

Review 1.  Macrocyclic inhibitors of hsp90.

Authors:  Victoria A Johnson; Erinprit K Singh; Lidia A Nazarova; Leslie D Alexander; Shelli R McAlpine
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

2.  The expression of Akt and ERK1/2 proteins decreased in dexamethasone-induced intrauterine growth restricted rat placental development.

Authors:  Asli Ozmen; Gozde Unek; Dijle Kipmen-Korgun; Emin Turkay Korgun
Journal:  J Mol Histol       Date:  2011-04-23       Impact factor: 2.611

3.  PIK3CA polymorphisms associated with susceptibility to hepatocellular carcinoma.

Authors:  Hong-Guang Li; Fang-Feng Liu; Hua-Qiang Zhu; Xu Zhou; Jun Lu; Hong Chang; Jin-Hua Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

4.  Flavonoids in modulation of cell survival signalling pathways.

Authors:  Mohammad Lukman Mansuri; Priyanka Parihar; Isha Solanki; Mordhwaj S Parihar
Journal:  Genes Nutr       Date:  2014-03-30       Impact factor: 5.523

Review 5.  GPR30: A G protein-coupled receptor for estrogen.

Authors:  Eric R Prossnitz; Jeffrey B Arterburn; Larry A Sklar
Journal:  Mol Cell Endocrinol       Date:  2007-01-11       Impact factor: 4.102

6.  Cardioprotective stimuli mediate phosphoinositide 3-kinase and phosphoinositide dependent kinase 1 nuclear accumulation in cardiomyocytes.

Authors:  Marta Rubio; Daniele Avitabile; Kimberlee Fischer; Gregory Emmanuel; Natalie Gude; Shigeki Miyamoto; Shikha Mishra; Eric M Schaefer; Joan Heller Brown; Mark A Sussman
Journal:  J Mol Cell Cardiol       Date:  2009-03-06       Impact factor: 5.000

7.  Upregulation of TRB2 induced by miR-98 in the early lesions of large artery of type-2 diabetic rat.

Authors:  Shuyang Xie; Ning Xie; Youjie Li; Pingyu Wang; Chao Zhang; Qiang Li; Xiaolin Liu; Jingti Deng; Can Zhang; Changjun Lv
Journal:  Mol Cell Biochem       Date:  2011-10-20       Impact factor: 3.396

8.  Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival.

Authors:  Amit Kumar; Javier Redondo-Muñoz; Vicente Perez-García; Isabel Cortes; Monica Chagoyen; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2011-03-07       Impact factor: 4.272

9.  TDRG1 regulates chemosensitivity of seminoma TCam-2 cells to cisplatin via PI3K/Akt/mTOR signaling pathway and mitochondria-mediated apoptotic pathway.

Authors:  Yu Gan; Yong Wang; Zhengyu Tan; Jun Zhou; Riko Kitazawa; Xianzhen Jiang; Yuxin Tang; Jianfu Yang
Journal:  Cancer Biol Ther       Date:  2016-04-22       Impact factor: 4.742

10.  PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.

Authors:  C J Guigon; L Zhao; M C Willingham; S-Y Cheng
Journal:  Oncogene       Date:  2008-11-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.